Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

Clicks: 383
ID: 266038
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #4 of 73 articles by views in Therapeutic drug monitoring

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The benefits of a pharmacy-based, active therapeutic drug monitoring (TDM) service (ATM) on outcomes were examined in a prospective study at four hospitals. ATM involved pharmacokinetic dosage optimization at the start of treatment, subsequent Bayesian adaptive control, and frequent patient evaluati …
Reference Key
na1999therapeuticimpact Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors van Lent-Evers NA;Mathôt RA;Geus WP;van Hout BA;Vinks AA;;
Journal Therapeutic drug monitoring
Year 1999
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/10051056
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male aged Comparative Study Prospective Studies Multicenter Study anti-bacterial agents / therapeutic use length of stay outcome assessment anti-bacterial agents / administration & dosage* cost-benefit analysis* anti-bacterial agents / economics anti-bacterial agents / pharmacokinetics gram-negative bacterial infections / metabolism aminoglycosides gram-negative bacterial infections / drug therapy pmid:10051056 doi:10.1097/00007691-199902000-00010 n a van lent-evers r a mathôt a a vinks drug monitoring / economics drug monitoring / methods gram-negative bacterial infections / economics health care*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.